Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC

INTRODUCTION: It is not known whether patients with NSCLC who are hospitalized because of cancer-related complications are liable to benefit from salvage immunotherapy. METHODS: This is a multicenter observational study including five centers, which involve all patients with advanced-stage NSCLC exh...

Descripción completa

Detalles Bibliográficos
Autores principales: Roborel de Climens, Ferréol, Chouaid, Christos, Poulet, Claire, Leroy, Vincent, Stoven, Luc, Cortot, Alexis Benjamin, Dhalluin, Xavier, Gauvain, Clément
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474254/
https://www.ncbi.nlm.nih.gov/pubmed/34590015
http://dx.doi.org/10.1016/j.jtocrr.2021.100147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474254/
https://www.ncbi.nlm.nih.gov/pubmed/34590015
http://dx.doi.org/10.1016/j.jtocrr.2021.100147

Ejemplares similares